Quick Answer
Connect Biopharma Holdings Ltd reported Stockholders Equity of $41.98 million for the year ending 2025.
- Connect Biopharma Holdings Ltd showed a decrease of -54.5% in Stockholders Equity from 2024 to 2025.
- This data is from Connect Biopharma Holdings Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $93.90 million | Q2 2024: $110.93 million | Q3 2024: $100.65 million | Q1 2025: $82.90 million | Q2 2025: $71.34 million | Q3 2025: $55.37 million.
- Over the full 4 years of available data (2022 to 2025), Connect Biopharma Holdings Ltd's Stockholders Equity has declined by 73.5%.
- Historical annual values: Fiscal year 2025: $41.98 million | Fiscal year 2024: $92.17 million | Fiscal year 2023: $101.50 million | Fiscal year 2022: $158.42 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: